Tetracyclic imidazo-benzodiazepines as GABA receptors modulators

Details for Australian Patent Application No. 2005315913 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Knust, Henner; Thomas, Andrew William; Buettelmann, Bernd

Agent Spruson & Ferguson

Pub. Number AU-B-2005315913

PCT Pub. Number WO2006/063708

Priority 04106556.6 14.12.04 EP

Filing date 5 December 2005

Wipo publication date 22 June 2006

Acceptance publication date 24 November 2011

International Classifications

C07D 487/14 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups

A61K 31/5517 (2006.01)

Event Publications

12 July 2007 PCT application entered the National Phase

  PCT publication WO2006/063708 Priority application(s): WO2006/063708

16 August 2007 Change of Name(s) of Applicant(s), Section 104

  F.Hoffmann-La Roche AG The name of the applicant has been changed to F. Hoffmann-La Roche AG

24 November 2011 Application Accepted

  Published as AU-B-2005315913

22 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315914-Biand tricyclic substituted phenyl methanones as glycine transporter I (GlyT-1) inhibitors for the treatment of Alzheimer's disease

2005315912-Novel pharmaceutical composition containing at least one Dolastatin 10 derivative